Prognostic significance of the C-reactive protein–albumin–lymphocyte index in patients with unresectable or recurrent gastric cancer treated with First-line fluoropyrimidine-based chemotherapy
Surgery Today · 2026-09 · 56 (9) · 1807-1815
DOI: 10.1007/s00595-026-03296-y ↗Kurz gefasst
Fachartikel in der Zeitschrift Surgery Today, online erschienen am 10.04.2026. Verfasst von Tomoyuki Matsunaga und 13 weiteren Autor:innen. Beteiligte Einrichtung: Division of Gastrointestinal and Pediatric Surgery, Department of Surgery, School of Medicine, Tottori University Faculty of Medicine, 36-1 Nishi-cho…. Die Arbeit nennt 19 Literaturangaben.
Themen: Onkologische Pflege
Abstract (Originalsprache)
Kein Abstract verfügbar.
Schlagwörter
Stichwörter der Autor:innen
Autor:innen und Institutionen
- Division of Gastrointestinal and Pediatric Surgery, Department of Surgery, School of Medicine, Tottori University Faculty of Medicine, 36-1 Nishi-cho, Yonago, 683-8504, Japan. matut0m0@tottori-u.ac.jp.
- Department of Surgery, Japanese Red Cross Tottori Hospital, Tottori, 680-8517, Japan.
- Division of Gastroenterology, Matsue City Hospital, Matsue, 690-8509, Japan.
- Department of Surgery, Japanese Red Cross Masuda Hospital, Masuda, 698-8501, Japan.
- Department of Surgery, Yonago Medical Center of National Hospital Organization, Yonago, 683-0006, Japan.
- National Hospital Organization, Hamada Medical Center, Hamada, 697-8511, Japan.
Zitieren
APA
Matsunaga, T., Saito, H., Fukumoto, Y., Kuroda, H., Taniguchi, K., Takahashi, S., Osaki, T., Iwamoto, A., Fukuda, K., Shimizu, S., Shishido, Y., Miyatani, K., Sakamoto, T., & Fujiwara, Y. (2026). Prognostic significance of the C-reactive protein–albumin–lymphocyte index in patients with unresectable or recurrent gastric cancer treated with First-line fluoropyrimidine-based chemotherapy. Surgery Today, 56(9), 1807-1815. https://doi.org/10.1007/s00595-026-03296-y
Vancouver
Matsunaga T, Saito H, Fukumoto Y, Kuroda H, Taniguchi K, Takahashi S, et al. Prognostic significance of the C-reactive protein–albumin–lymphocyte index in patients with unresectable or recurrent gastric cancer treated with First-line fluoropyrimidine-based chemotherapy. Surgery Today. 2026;56(9):1807-1815. doi:10.1007/s00595-026-03296-y
BibTeX
@article{Matsunaga2026,
author = {Matsunaga, Tomoyuki and Saito, Hiroaki and Fukumoto, Yoji and Kuroda, Hirohiko and Taniguchi, Kenjiro and Takahashi, Sadamu and Osaki, Tomohiro and Iwamoto, Akemi and Fukuda, Kenji and Shimizu, Shota and Shishido, Yuji and Miyatani, Kozo and Sakamoto, Teruhisa and Fujiwara, Yoshiyuki},
title = {Prognostic significance of the C-reactive protein–albumin–lymphocyte index in patients with unresectable or recurrent gastric cancer treated with First-line fluoropyrimidine-based chemotherapy},
journal = {Surgery Today},
year = {2026},
volume = {56},
number = {9},
pages = {1807--1815},
doi = {10.1007/s00595-026-03296-y}
}
EUVIMED